Silica nanostructures, large-scale fabrication methods, and applications thereof
US-2018065859-A1 · Mar 8, 2018 · US
US12102716B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12102716-B2 |
| Application number | US-202217823750-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 31, 2022 |
| Priority date | May 3, 2019 |
| Publication date | Oct 1, 2024 |
| Grant date | Oct 1, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention pertains to a method for treating a neoplasm, such as colorectal cancer, using hollow silica spheres (“HSS”). It also is directed to a method for making uncalcined HSS, calcined HSS from which phenyl groups have been removed, and HSS incorporating particles of Fe 3 O 4 , as well as compositions containing HSS.
Opening claim text (preview).
The invention claimed is: 1. A method for forming hollow silica spheres incorporating Fe 3 O 4 (“Fe-HSS”) comprising: dissolving a hydrolyzable aryl silane in an aqueous solution comprising Fe 3 O 4 , water and an acid to form a hydrolyzed silane solution, wherein a molar ratio of the hydrolysable aryl silane to the Fe 3 O 4 ranges from 100:1 to 1: 100; mixing the hydrolyzed silane solution with a hydroxide base to form a precipitated Fe-HSS; and recovering the precipitated Fe-HSS from the precipitate to form recovered Fe-HSS, then calcining the recovered Fe-HSS to form Fe—HSS having surfaces that comprise no phenyl or aryl groups, wherein the calcining is carried out in two stages including a first stage of heating at a rate of 3 to 10° C./min to a first temperature of 180 to 240° C. and holding at the first temperature for about 15 minutes to 45 minutes, and a second stage of heating at a rate of 1° C. to 2° C./min to a second temperature of 600 to 740° C. and holding at the second temperature for about 12 hours to 24 hours, wherein the Fe-HSS are formed template-free without the use of a sacrificial core, and wherein the Fe-HSS have a hollow core space containing plural individual particles of Fe 3 O 4 having an average diameter in a range of from 9.5 nm to 21.3 nm and the Fe 3 O 4 has a spinel structure, wherein the hollow silica spheres of the Fe 3 O 4 hollow silica spheres have a core-shell structure with shells larger in thickness than cores, and the hollow silica spheres have an average diameter in a range of from 415 to 615 nm, wherein the hollow silica spheres of the Fe 3 O 4 hollow silica spheres have an average diameter less than the average diameter of the corresponding uncalcined Fe-HSS; and wherein the particles of Fe 3 O 4 are present in an amount of from 0.1 to 10 wt. % of a combined weight of the HSS and Fe 3 O 4 in the Fe-HSS. 2. The method of claim 1 , wherein the hydrolyzable aryl silane is trimethoxy (phenyl) silane and the hydroxide base is NH 4 OH. 3. The method of claim 1 , wherein the calcining includes first heating the recovered Fe-HSS at a temperature of 200° C. for 30 minutes, then heating at a temperature of 660° C. for 16 hours. 4. The method of claim 3 , wherein the first stage includes ramping the temperature of the Fe-HSS at a heating rate of 5° C./min, and the second stage includes ramping the temperature of the Fe-HSS at a heating rate of 1.5° C./min. 5. The method of claim 1 , comprising: first mixing Fe 3 O 4 with a solution of HNO 3 , then adding trimethoxy (phenyl) silane to form a first mixture which is agitated, then mixing a solution of NH 4 OH with the first mixture to form a second mixture. 6. The method of claim 1 , wherein the hollow silica spheres are prepared by a process comprising hydrolysis of a mixture comprising Fe 3 O 4 and phenyl-tri-methoxysilane (“PTMS”) followed by condensation with a hydroxide base.
Medicinal preparations containing inorganic active ingredients · CPC title
Antineoplastic agents · CPC title
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title
Processes · CPC title
Iron; Compounds thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.